Chemoinformaics analysis of 2(3H)-Furanone, dihydro-3-methyl-, (R)-
| Molecular Weight | 100.117 | nRot | 0 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 6 |
| Exact Molecular Weight | 100.052 | nRing | 1 |
| Solubility: LogS | -6.948 | nHRing | 1 |
| Solubility: LogP | 7.624 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.2883 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.424 |
| Synth | 2.202 |
| Natural Product Likeliness | 0.428 |
| NR-PPAR-gamma | 0.07 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.3 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.516 |
| MDCK | 0.00000869 |
| BBB | 0.247 |
| PPB | 0.985248 |
| VDSS | 2.487 |
| FU | 0.00944045 |
| CYP1A2-inh | 0.595 |
| CYP1A2-sub | 0.494 |
| CYP2c19-inh | 0.601 |
| CYP2c19-sub | 0.217 |
| CYP2c9-inh | 0.392 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.155 |
| CYP2d6-sub | 0.118 |
| CYP3a4-inh | 0.453 |
| CYP3a4-sub | 0.217 |
| CL | 5.339 |
| T12 | 0.055 |
| hERG | 0.18 |
| Ames | 0.01 |
| ROA | 0.095 |
| SkinSen | 0.934 |
| Carcinogencity | 0.066 |
| EI | 0.989 |
| Respiratory | 0.187 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.940861 |